Skip to main content

Research Repository

Advanced Search

The HOME Core outcome set for clinical trials of atopic dermatitis

Williams, Hywel C.; Schmitt, Jochen; Thomas, Kim S.; Spuls, Phyllis I.; Simpson, Eric L.; Apfelbacher, Christian J.; Chalmers, Joanne R.; Furue, Masutaka; Katoh, Norito; Gerbens, Louise A.A.; Leshem, Yael A.; Howells, Laura; Singh, Jasvinder A.; Boers, Maarten

The HOME Core outcome set for clinical trials of atopic dermatitis Thumbnail


Authors

Profile image of HYWEL WILLIAMS

HYWEL WILLIAMS HYWEL.WILLIAMS@NOTTINGHAM.AC.UK
Professor of Dermato-Epidemiology

Jochen Schmitt

Phyllis I. Spuls

Eric L. Simpson

Christian J. Apfelbacher

Joanne R. Chalmers

Masutaka Furue

Norito Katoh

Louise A.A. Gerbens

Yael A. Leshem

LAURA HOWELLS LAURA.HOWELLS1@NOTTINGHAM.AC.UK
Senior Research Fellow

Jasvinder A. Singh

Maarten Boers



Abstract

Core outcome sets are critically important outcomes that should be measured in clinical trials. Their absence in atopic dermatitis is a form of research waste and impedes combining evidence to inform patient care. Here, we articulate the rationale for core outcome sets in atopic dermatitis and review the work of the international Harmonising Outcome Measures for Eczema group from its inception in Munich, 2010. We describe core domain determination (what should be measured), to instrument selection (how domains should be measured), culminating in the complete core outcome measurement set in Tokyo, 2019. Using a “road map,” Harmonising Outcome Measures for Eczema includes diverse research methods including Delphi and nominal group techniques informed by systematic reviews of properties of candidate instruments. The 4 domains and recommended instruments for including in all clinical trials of atopic dermatitis are patient symptoms, measured by Patient-Oriented Eczema Measure and peak Numerical Rating Scale 11 for itch intensity over 24 hours, clinical signs measured using the Eczema Area and Severity Index, quality of life measured by the Dermatology Life Quality Index series for adults, children, and infants, and long-term control measured by either Recap of atopic eczema or Atopic Dermatitis Control Tool.

Citation

Williams, H. C., Schmitt, J., Thomas, K. S., Spuls, P. I., Simpson, E. L., Apfelbacher, C. J., …Boers, M. (2022). The HOME Core outcome set for clinical trials of atopic dermatitis. Journal of Allergy and Clinical Immunology, 149(6), 1899-1911. https://doi.org/10.1016/j.jaci.2022.03.017

Journal Article Type Article
Acceptance Date Mar 11, 2022
Online Publication Date Mar 26, 2022
Publication Date 2022-06
Deposit Date Mar 18, 2022
Publicly Available Date Mar 27, 2023
Journal Journal of Allergy and Clinical Immunology
Print ISSN 0091-6749
Electronic ISSN 1097-6825
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 149
Issue 6
Pages 1899-1911
DOI https://doi.org/10.1016/j.jaci.2022.03.017
Keywords Immunology; Immunology and Allergy
Public URL https://nottingham-repository.worktribe.com/output/7610732
Publisher URL https://www.jacionline.org/article/S0091-6749(22)00389-X/pdf
Related Public URLs https://www.sciencedirect.com/science/article/abs/pii/S009167492200389X
Additional Information Authors on behalf of the HOME Initiative.

Files





You might also like



Downloadable Citations